Medications for Opioid Use Disorder
$40.00 | CE Hours:8.00 | Intermediate
CE Course Description
The U.S. faces a crisis of overdose deaths from opioids, including heroin, illicit fentanyl, and prescription opioids. These deaths represent a small fraction of the total number of Americans impacted by opioid misuse and addiction. Millions of Americans suffer daily from a chronic medical illness called opioid use disorder (OUD), and research indicates that both opioid-related overdose deaths and OUD may be on the rise. As a result, healthcare professionals should possess insight into evidence-based, effective treatment and support care for individuals suffering from OUD. This course reviews the Treatment Improvement Protocol, which provides an overview of the medications, strategies, and services needed to effectively treat and support OUD and opioid use recovery, to provide healthcare professionals with the necessary insight to administer safe and effective healthcare to patients in need.
Author: The Substance Abuse and Mental Health Services Administration (SAMHSA) U.S. Department of Health and Human Services in conjunction with select nonfederal clinical researchers, service providers, program administrators, and patient advocates as a consensus panel offering input on specific topics in their areas of expertise to reach consensus on best practices. Field reviewers then assess draft content and finalize the TIP manual.
1. Centers for Disease Control and Prevention, National Center for Health Statistics. (2020). Multiple Cause of Death 1999-2018 on CDC WONDER Online Database, released in 2020. Retrieved March 12, 2020, from http://wonder.cdc.gov/mcd-icd10.html
2. National Highway Traffic Safety Administration. (2020). Fatal Motor Vehicle Crashes. Years: 2018. Retrieved March 12, 2020, from https://cdan.dot.gov/ SASStoredProcess/guest
3. Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (2001). The Alcohol Use Disorders Identification Test. Guidelines for use in primary care (2nd ed.). Geneva, Switzerland: The World Health Organization.
CE Course Objectives
Evaluate the key facts and issues related to providing Food and Drug Administration (FDA)-approved medications used to treat OUD.
Identify patients’ needs related to OUD screening, assessment, and treatment (or referral to specialty treatment).
Distinguish between the different substance misuse and SUD screening methods and tools.
Describe the general principles of OUD pharmacotherapy as well as medication formulations, indications, and dosing for the three medications used to treat OUD - methadone, naltrexone, and buprenorphine.
Recognize the role of addiction treatment counselors in OUD treatment, as well as the importance of effective partnerships between addiction treatment counselors and healthcare professionals.
Integrate resources related to OUD in patient care.
CE Outline with Main Points
- Executive Summary
- Introduction to Medications for Opioid Use Disorder Treatments
- Addressing Opioid Use Disorder in General Medical Settings
- Pharmacotherapy for Opioid Use Disorder
- Partnering Addiction Treatment Counselors With Clients and Healthcare Professionals
- Resources Related to Medications for Opioid Use Disorder
Social Work Approval
Social Work CE Credit for this course is offered with the following approvals. Many state boards of social work will accept the approvals listed. Provider Approvals by state and license type can be found here.
- Quantum Units Education is approved by the California Association of Marriage and Family Therapists, CAMFT Provider #89970, to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEP. Quantum Units Education maintains responsibility for this program/course and its content.
- Florida board for Social Workers CE Provider #50-8650 (Quantum 'immediately' reports CE Credits to Florida licensees)
- Illinois Department of Professional Regulation, License No. 159.001261 approved CE Sponsor
- Ohio CSWMFTB #RCST091701 approved CE Provider
- Texas Board of SWE #5070 approved CE Provider
- Quantum Units Education, #1289, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 01/03/2020 - 01/03/2023. Social workers completing this course receive 8.00 'General' continuing education credits.
To see other approvals in your state, see our state by state provider approval listings here.
This course is CAADE approved.
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.
Added On: 2021-06-26